Trending

lupus nephritis

GSK’s Benlysta claims first FDA okay for lupus kidney damage

GSK’s Benlysta claims first FDA okay for lupus kidney damage

GlaxoSmithKline’s Benlysta has been on the market for almost a decade, but it still has some tricks up

X

GSK’s Benlysta claims first FDA okay for lupus kidney damage

https://pharmaphorum.com/news/gsks-benlysta-claims-first-fda-okay-for-lupus-kidney-damage/

AZ fleshes out positive trial of revitalised lupus drug anifrolumab

AZ fleshes out positive trial of revitalised lupus drug anifrolumab

After being all-but written off a year ago, AstraZeneca’s anifrolumab has been reborn with new data that suggest

X

AZ fleshes out positive trial of revitalised lupus drug anifrolumab

https://pharmaphorum.com/news/az-fleshes-out-positive-trial-of-revitalised-lupus-drug-anifrolumab/

Aurinia scores big win in lupus nephritis trial

Aurinia scores big win in lupus nephritis trial

Trial is first ever to meet primary endpoint in disease

X

Aurinia scores big win in lupus nephritis trial

https://pharmaphorum.com/news/aurinia-scores-big-win-lupus-nephritis-trial/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com